Notification about latest news from us.
Regeneron Pharmaceuticals to acquire 23andMe for $256 million post-bankruptcy, focusing on customer DNA data privacy amid concerns.
Colossal Biosciences advances de-extinction by creating a "woolly mouse" with traits resembling the extinct woolly mammoth's cold adaptations.
Dr Krishna Ella has been awarded the 2025 INSA fellowship, recognizing his contributions to vaccine development and biotechnology.
BrainAurora shares traded flat in its Hong Kong IPO debut, raising hopes for the city's future as a top IPO venue.
WuXi Biologics is selling its Irish vaccine facility to Merck for $500 million amid potential US restrictions on Chinese biotech firms.
WuXi Biologics sells its Irish vaccine facility to Merck for $500 million as US restrictions on Chinese biotech loom.
The crisis at New Horizon Health escalates with the resignation of its chairman and CEO amidst serious allegations of inflated sales figures.
New Horizon Health faces a crisis following CEO resignation amid accusations of inflated sales figures, leading to share suspension.
By clicking send you'll receive occasional emails from newsletters about this topic.